Content area

|
|

Sparsom evidens for effekt og sikkerhed af propranolol ved eksamensangst

Forfatter(e)
Siri Vinther, Søren Bøgevig, Tonny Studsgaard Petersen, Kim Peder Dalhoff & Kasper Meidahl Petersen Klinisk Farmakologisk Afdeling, Bispebjerg
og Frederiksberg Hospitaler

Ugeskr Læger 2018;180:V06180417
Reference: 
Ugeskr Læger 2018;180:V06180417
Blad nummer: 

Siri Vinther, Søren Bøgevig, Tonny Studsgaard Petersen,
Kim Peder Dalhoff & Kasper Meidahl Petersen:

Limited evidence for effect and safety of propranolol for exam-related anxiety

Ugeskr Læger 2018;180:V06180417

Propranolol is often prescribed to younger people with exam-related performance anxiety. Evidence for effect as well as safety is, however, sparse for this non-approved indication. Furthermore, only relatively large pack sizes are available in Denmark. This may spur an unnecessary, permanent overuse and increase the risk of overdosing and poisoning. The aim of this review is to examine the evidence for the effect as well as safety of propranolol for exam-related performance anxiety and to discuss, whether the use of this drug for this unapproved indication is rational.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Stig Gerdes | 18/03
4 kommentarer
af Kjartan Hannig | 18/03
4 kommentarer
af Gorm Greisen | 17/03
1 Kommentar
af Lars Erik Larsen | 17/03
5 kommentarer
af Frede Simonsen | 13/03
1 Kommentar
af Bo Hasseriis Hansen | 13/03
5 kommentarer
af Jim Innocent Ngoga | 11/03
27 kommentarer